Common Contracts
2 similar First Supplemental Indenture contracts by Tilray Brands, Inc., Xeris Pharmaceuticals Inc
TILRAY BRANDS, INC. and Computershare Trust Company, N.A. as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of May 31, 2023 5.20% Convertible Senior Notes due 2027First Supplemental Indenture • May 31st, 2023 • Tilray Brands, Inc. • Medicinal chemicals & botanical products • New York
THIS FIRST SUPPLEMENTAL INDENTURE, dated as of May 31, 2023 (the “Supplemental Indenture”), to the Indenture, dated as of May 31, 2023 (the “Base Indenture” and, as amended, modified and supplemented by this Supplemental Indenture, the “Indenture”), between Tilray Brands, Inc., a Delaware corporation, as issuer (the “Company”) and Computershare Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
XERIS PHARMACEUTICALS, INC. and as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of June 30, 2020First Supplemental Indenture • July 1st, 2020 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Supplemental Indenture (as defined below) is being executed and delivered pursuant to Sections 2.01 and 2.02 of the Base Indenture (as defined below) to establish the terms, and provide for the issuance, of a new series of Securities (as defined in the Base Indenture) constituting the Company’s 5.00% Convertible Senior Notes due 2025 (the “Notes”).
